Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 227 entries
View as:

Enzalutamide and Cabazitaxel in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02522715 Org: User:
Start: 08/13/15 End: 01/01/26 Due: 01/01/27

Methotrexate, Cyclophosphamide, and Etoposide Phosphate Given With Osmotic Blood-Brain Barrier Disruption Plus Dexamethasone and Cytarabine in Treating Patients With Primary CNS Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00074178 Org: User:
Start: 01/31/00 End: 07/31/06 Due: 07/31/07

Use of Indocyanine Green in Pancreas Surgery

Phase: N/A Priority: Normal
NCT ID: NCT06084013 Org: User:
Start: 05/17/24 End: 02/28/26 Due: 02/28/27

Advanced ChemoHormonal Therapy for Treatment Naive Metastatic Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04267887 Org: User:
Start: 05/11/20 End: 01/01/30 Due: 01/01/31

BEST-RPP Pilot: Screening for Esophageal Cancer in Rural Oregon Without an Endoscopy

Phase: N/A Priority: Normal
NCT ID: NCT06335966 Org: User:
Start: 09/11/24 End: 01/30/26 Due: 01/30/27

SMMART Adaptive Clinical Treatment (ACT) Trial

Phase: N/A Priority: Normal
NCT ID: NCT05238831 Org: User:
Start: 01/30/23 End: 05/31/26 Due: 05/31/27

Olaparib and Durvalumab in Treating Participants With Metastatic Triple Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03544125 Org: User:
Start: 05/03/18 End: 11/18/20 Due: 11/18/21

DCE MRI in Patients With Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02070705 Org: User:
Start: 01/31/14 End: 08/07/24 Due: 08/07/25

Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AML

Phase: N/A Priority: Normal
NCT ID: NCT06504459 Org: User:
Start: 01/03/25 End: 05/01/28 Due: 05/01/29

Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT00324324 Org: User:
Start: 05/31/06 End: 12/31/12 Due: 12/31/13

Electronic Quitline Referral with Enhanced Academic Detailing for the Promotion of Smoking Cessation

Phase: N/A Priority: Normal
NCT ID: NCT04969978 Org: User:
Start: 06/20/23 End: 03/31/26 Due: 03/31/27

Effects of Simulated Solar Radiation on Human Skin in Preventing Skin Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05027009 Org: User:
Start: 11/18/21 End: 06/02/22 Due: 06/02/23

Computer-Based Behavior Change Guide in Increasing Physical Activity in Patients With Prostate Cancer Who Have Received Androgen Deprivation Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02869412 Org: User:
Start: 01/31/15 End: 07/31/17 Due: 07/31/18

Personalized Kinase Inhibitor Therapy Combined With Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT02779283 Org: User:
Start: 01/13/16 End: 09/20/18 Due: 09/20/19

Identifying and Caring for Individuals With Inherited Cancer Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT04494945 Org: User:
Start: 03/09/20 End: 06/10/30 Due: 06/10/31

Hyperspectral Endoscopy Imaging for the Early Detection of Precancerous Lesions in Average Risk Patients

Phase: N/A Priority: Normal
NCT ID: NCT04172493 Org: User:
Start: 08/26/19 End: 01/27/20 Due: 01/27/21

Compassionate Use Ponatinib

Phase: N/A Priority: Normal
NCT ID: NCT01549548 Org: User:
Start: - End: - Due: -

JNJ-40346527 in Treating Participants With Relapsed or Refractory Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT03557970 Org: User:
Start: 10/05/18 End: 09/28/20 Due: 09/28/21

Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05705492 Org: User:
Start: 07/17/24 End: 01/01/26 Due: 01/01/27

The Use of "Smart" Body-Weight Scales for Weight and Nutritional Monitoring in Patients With Head and Neck Cancer Undergoing Radiation Therapy

Phase: N/A Priority: Normal
NCT ID: NCT05457478 Org: User:
Start: 01/13/23 End: 09/13/23 Due: 09/13/24

Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06067438 Org: User:
Start: 06/21/24 End: 08/30/26 Due: 08/30/27

Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy

Phase: N/A Priority: Normal
NCT ID: NCT05919329 Org: User:
Start: 06/25/24 End: 09/01/30 Due: 09/01/31

Observational Study of Sex Differences in Symptoms During Immune Checkpoint Inhibitor Treatment for People With Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06562777 Org: User:
Start: 09/15/23 End: 07/31/25 Due: 07/31/26

Glucarpidase After High-Dose Methotrexate in Patients with Osteosarcoma

Phase: N/A Priority: Normal
NCT ID: NCT03960177 Org: User:
Start: 03/27/19 End: 06/01/26 Due: 06/01/27

Swallowable Sponge Cell Sampling Device and Next Generation Sequencing in Detecting Esophageal Cancer in Patients With Low or High Grade Dysplasia, Barrett Esophagus, or Gastroesophageal Reflux Disease

Phase: N/A Priority: Normal
NCT ID: NCT02890979 Org: User:
Start: 08/03/16 End: 10/10/17 Due: 10/10/18